Clinical Trial: Latency Antibiotics for Previable Rupture Of Membranes Trial

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06917157) titled 'Latency Antibiotics for Previable Rupture Of Membranes Trial' on March 31.

Brief Summary: The purpose of this study is to see if the use of prophylactic antibiotics in the expectant management of PPROM less than 22 weeks significantly reduce the rate of delivery within 7 days and to see if the use of prophylactic antibiotics in the expectant management of PPROM between 20 and 22 weeks decrease composite neonatal morbidity.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Preterm Prelabor Rupture of Membranes (PPROM)

Intervention: DRUG: Administration of antibiotics prophylactically at the time of membrane rupture...